INSIDER · CIK 1219927
Tabuteau Herriot
Chief Executive Officer, Director, 10% Owner at Axsome Therapeutics, Inc. (AXSM)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$10.5MSold on the market
1Companies
Aug 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 202619:00 | Aug 6, 2026from Aug 5, 2026 | AXSMAxsome Therapeutics, Inc. | Chief Executive Officer, Director, 10% Owner | S · Sell10b5-1 | $212.19 | −49,664 | 7,229 | -87% | −$10.5M | ||
| Aug 7, 202619:00 | Aug 6, 2026from Aug 5, 2026 | AXSMAxsome Therapeutics, Inc. | Chief Executive Officer, Director, 10% Owner | M · Exercise10b5-1 | $4.95 | +49,664 | 11,889 | — | $246K |